{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T17:01:58Z","timestamp":1789146118304,"version":"build-2803163510"},"reference-count":34,"publisher":"Japan Atherosclerosis Society","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAT","J Atheroscler Thromb"],"published-print":{"date-parts":[[2026,5,1]]},"DOI":"10.5551\/jat.65995","type":"journal-article","created":{"date-parts":[[2025,12,24]],"date-time":"2025-12-24T22:26:49Z","timestamp":1766615209000},"page":"578-588","source":"Crossref","is-referenced-by-count":2,"title":["Association of Achilles Tendon Thickness with Severity of Coronary Artery Disease in Non -Familial Hypercholesterolemia"],"prefix":"10.5551","volume":"33","author":[{"given":"Shimpei","family":"Fujioka","sequence":"first","affiliation":[{"name":"Department of Cardiology, Osaka Medical and Pharmaceutical University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daisuke","family":"Shishikura","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Osaka Medical and Pharmaceutical University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenta","family":"Sakaguchi","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Osaka Medical and Pharmaceutical University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirofumi","family":"Kusumoto","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Osaka Medical and Pharmaceutical University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahito","family":"Michikura","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Osaka Medical and Pharmaceutical University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yumiko","family":"Kanzaki","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Osaka Medical and Pharmaceutical University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariko","family":"Harada-Shiba","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Osaka Medical and Pharmaceutical University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideaki","family":"Morita","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Osaka Medical and Pharmaceutical University"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"3489","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Hobbs HH, Russell DW, Brown MS, and Goldstein JL: The LDL receptor locus in familial hypercholesterolemia: mutational analysis of a membrane protein. Annu Rev Genet, 1990; 24: 133-170","DOI":"10.1146\/annurev.ge.24.120190.001025"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Schmidt HH, Hill S, Makariou EV, Feuerstein IM, Dugi KA, and Hoeg JM: Relation of cholesterol-year score to severity of calcific atherosclerosis and tissue deposition in homozygous familial hypercholesterolemia. Am J Cardiol, 1996; 77: 575-580","DOI":"10.1016\/S0002-9149(97)89309-5"},{"key":"3","unstructured":"3) Ose L: [Muller-Harbitz disease--familial hypercholesterolemia]. Tidsskr Nor Laegeforen, 2002; 122: 924-925"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Tsouli SG, Kiortsis DN, Argyropoulou MI, Mikhailidis DP, and Elisaf MS: Pathogenesis, detection and treatment of Achilles tendon xanthomas. Eur J Clin Investig, 2005; 35: 236-244","DOI":"10.1111\/j.1365-2362.2005.01484.x"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Hovingh GK, Davidson MH, Kastelein JJ, and O\u2019Connor AM: Diagnosis and treatment of familial hypercholesterolaemia. Eur Heart J, 2013; 34: 962-971","DOI":"10.1093\/eurheartj\/eht015"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Marks D, Thorogood M, Neil HA, and Humphries SE: A review on the diagnosis, natural history, and treatment of familial hypercholesterolaemia. Atherosclerosis, 2003; 168: 1-14","DOI":"10.1016\/S0021-9150(02)00330-1"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Tsouli SG, Kiortsis DN, Lourida ES, Xydis V, Tsironis LD, Argyropoulou MI, Elisaf M, Tselepis AD: Autoantibody titers against OxLDL are correlated with Achilles tendon thickness in patients with familial hypercholesterolemia. J Lipid Res, 2006; 47: 2208-2214","DOI":"10.1194\/jlr.M600109-JLR200"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Michikura M, Ogura M, Hori M, Matsuki K, Makino H, Fujioka S, Shishikura D, Hoshiga M, Harada-Shiba M: Association of Achilles tendon thickness with lipid profile and carotid IMT in patients with familial hypercholesterolemia. Atherosclerosis, 2025; 403: 119173","DOI":"10.1016\/j.atherosclerosis.2025.119173"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Adorni MP, Biolo M, Zimetti F, Palumbo M, Ronda N, Scarinzi P, Simioni P, Lupo MG, Ferri N, Previato L, Bernini F, Zambon A: HDL cholesterol efflux and serum cholesterol loading capacity alterations associate to macrophage cholesterol accumulation in FH patients with Achilles tendon xanthoma. Int J Mol Sci, 2022; 23: 8255","DOI":"10.3390\/ijms23158255"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Corredoira P, Marco-Benedi V, Cenarro A, Perib\u00e1\u00f1ez S, Olmos S, and Civeira F: Factors associated with the presence of tendon xanthomas in familial hypercholesterolemia. Rev Esp Cardiol (Engl Ed), 2024; 77: 462-470","DOI":"10.1016\/j.rec.2023.12.003"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Descamps OS, Leysen X, Van Leuven F, and Heller FR: The use of Achilles tendon ultrasonography for the diagnosis of familial hypercholesterolemia. Atherosclerosis, 2001; 157: 514-518","DOI":"10.1016\/S0021-9150(01)00533-0"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Michikura M, Ogura M, Hori M, Matsuki K, Makino H, Hosoda K, Harada-Shiba M: Association between Achilles tendon softness and atherosclerotic cardiovascular disease in patients with familial hypercholesterolemia. J Atheroscler Thromb, 2022; 29: 1603-1612","DOI":"10.5551\/jat.63151"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Michikura M, Ogura M, Matsuki K, Yamaoka M, Makino H, and Harada-Shiba M: Risk assessment for cardiovascular events using Achilles tendon thickness and softness and intima-media thickness in familial hypercholesterolemia. J Atheroscler Thromb, 2024; 31: 1607-1619","DOI":"10.5551\/jat.64766"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) Nordestgaard BG, Chapman MJ, Humphries SE, Ginsberg HN, Masana L, Descamps OS, Wiklund O, Hegele RA, Raal FJ, Defesche JC, Wiegman A, Santos RD, Watts GF, Parhofer KG, Hovingh GK, Kovanen PT, Boileau C, Averna M, Bor\u00e9n J, Bruckert E, Catapano AL, Kuivenhoven JA, Pajukanta P, Ray K, Stalenhoef AFH, Stroes E, Taskinen MR, Tybj\u00e6rg-Hansen A, European Atherosclerosis Society Consensus Panel: Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: consensus statement of the European Atherosclerosis Society. Eur Heart J, 2013; 34: 3478-390a","DOI":"10.1093\/eurheartj\/eht273"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) Risk of fatal coronary heart disease in familial hypercholesterolaemia. Scientific Steering Committee on behalf of the Simon Broome Register Group. BMJ, 1991; 303: 893-896","DOI":"10.1136\/bmj.303.6807.893"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16) Craig IH: Make early diagnosis, prevent early death from familial hypercholesterolaemia. The MED-PED FH program. Med J Aust, 1995; 162: 454-455","DOI":"10.5694\/j.1326-5377.1995.tb140001.x"},{"key":"17","unstructured":"17) Lehtonen A, M\u00e4kel\u00e4 P, Viikari J, and Virtama P: Achilles tendon thickness in hypercholesterolaemia. Ann Clin Res, 1981; 13: 39-44"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18) Tada H, Hori M, Matsuki K, Ogura M, Nohara A, Kawashiri MA, Harada-Shiba M: Achilles tendon thickness assessed by X-ray predicting a pathogenic mutation in familial hypercholesterolemia gene. J Atheroscler Thromb, 2022; 29: 816-824","DOI":"10.5551\/jat.62869"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19) Takeji Y, Tada H, Takamura M, Tomura A, and Harada-Shiba M: Prevalence and Clinical Characteristics of Familial hypercholesterolemia in Patients with Acute Coronary Syndrome according to the Current Japanese Guidelines: insight from the EXPLORE-J study. J Atheroscler Thromb, 2025; 32: 23-33","DOI":"10.5551\/jat.64972"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20) Michikura M, Ogura M, Yamamoto M, Sekimoto M, Fuke C, Hori M, Arai K, Kihara S, Hosoda K, Yanagi K, Harada-Shiba M: Achilles tendon ultrasonography for diagnosis of familial hypercholesterolemia among Japanese subjects. Circ J, 2017; 81: 1879-1885","DOI":"10.1253\/circj.CJ-17-0041"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21) De Montmollin M, B\u00e9trisey S, Feller M, Moutzouri E, Blum MR, Amsler J, Papazoglou DD, M\u00f6ller B, Rodondi N: Achilles tendon ultrasonography in the clinical screening of familial hypercholesterolaemia - a cross-sectional analysis. Swiss Med Wkly, 2023; 153: 40127","DOI":"10.57187\/smw.2023.40127"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22) Harada-Shiba M, Arai H, Ohmura H, Okazaki H, Sugiyama D, Tada H, Dobashi K, Matsuki K, Minamino T, Yamashita S, Yokote K: Guidelines for the diagnosis and treatment of adult familial hypercholesterolemia 2022. J Atheroscler Thromb, 2023; 30: 558-586","DOI":"10.5551\/jat.CR005"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23) Park DW, Clare RM, Schulte PJ, Pieper KS, Shaw LK, Califf RM, Ohman EM, Van De Werf F, Hirji S, Harrington RA, Armstrong PW, Granger CB, Jeong MH, Patel MR: Extent, location, and clinical significance of non-infarct-related coronary artery disease among patients with ST-elevation myocardial infarction. JAMA, 2014; 312: 2019-2027","DOI":"10.1001\/jama.2014.15095"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24) Sorajja P, Gersh BJ, Cox DA, McLaughlin MG, Zimetbaum P, Costantini C, Stuckey T, Tcheng JE, Mehran R, Lansky AJ, Grines CL, Stone GW: Impact of multivessel disease on reperfusion success and clinical outcomes in patients undergoing primary percutaneous coronary intervention for acute myocardial infarction. Eur Heart J, 2007; 28: 1709-1716","DOI":"10.1093\/eurheartj\/ehm184"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25) Faro DC, Laudani C, Agnello FG, Ammirabile N, Finocchiaro S, Legnazzi M, Mauro MS, Mazzone PM, Occhipinti G, Rochira C, Scalia L, Spagnolo M, Greco A, Capodanno D: Complete percutaneous coronary revascularization in acute coronary syndromes with multivessel coronary disease: A systematic review. JACC Cardiovasc Interv, 2023; 16: 2347-2364","DOI":"10.1016\/j.jcin.2023.07.043"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26) Naruse M, Katabami T, Shibata H, Sone M, Takahashi K, Tanabe A, Izawa S, Ichijo T, Otsuki M, Omura M, Ogawa Y, Oki Y, Kurihara I, Kobayashi H, Sakamoto R, Satoh F, Takeda Y, Tanaka T, Tamura K, Tsuiki M, Hashimoto S, Hasegawa T, Yoshimoto T, Yoneda T, Yamamoto K, Rakugi H, Wada N, Saiki A, Ohno Y, Haze T: Japan Endocrine Society clinical practice guideline for the diagnosis and management of primary aldosteronism 2021. Endocr J, 2022; 69: 327-359","DOI":"10.1507\/endocrj.EJ21-0508"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27) Friedewald WT, Levy RI, and Fredrickson DS: Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem, 1972; 18: 499-502","DOI":"10.1093\/clinchem\/18.6.499"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28) Siddiqui R, Mriza EH, Javed R, and Al-Qahtani M: Investigation of the tissue degenerative impact of increased BMI in Achilles tendon via strain elastography and finite element analysis. Curr Med Imaging, 2023; 19: 587-595","DOI":"10.2174\/1573405618666220805101527"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29) Hoursalas A, Tsarouhas K, Tsitsimpikou C, Kolovou G, Vardavas A, Hoursalas I, Spandidos DA, Milionis H, Elisaf M, Tsiara S: Moderately elevated lipoprotein (a) levels are associated with an earlier need for percutaneous coronary intervention in recurrent cardiovascular disease. Exp Ther Med, 2022; 24: 444","DOI":"10.3892\/etm.2022.11371"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30) Bor\u00e9n J, Chapman MJ, Krauss RM, Packard CJ, Bentzon JF, Binder CJ, Daemen MJ, Demer LL, Hegele RA, Nicholls SJ, Nordestgaard BG, Watts GF, Bruckert E, Fazio S, Ference BA, Graham I, Horton JD, Landmesser U, Laufs U, Masana L, Pasterkamp G, Raal FJ, Ray KK, Schunkert H, Taskinen MR, Van De Sluis B, Wiklund O, Tokgozoglu L, Catapano AL, Ginsberg HN: Low-density lipoproteins cause atherosclerotic cardiovascular disease: pathophysiological, genetic, and therapeutic insights: a consensus statement from the European Atherosclerosis Society Consensus Panel. Eur Heart J, 2020; 41: 2313-2330","DOI":"10.1093\/eurheartj\/ehz962"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31) Virmani R, Kolodgie FD, Burke AP, Farb A, and Schwartz SM: Lessons from sudden coronary death: a comprehensive morphological classification scheme for atherosclerotic lesions. Arterioscler Thromb Vasc Biol, 2000; 20: 1262-1275","DOI":"10.1161\/01.ATV.20.5.1262"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32) Akioyamen LE, Genest J, Chu A, Inibhunu H, Ko DT, and Tu JV: Risk factors for cardiovascular disease in heterozygous familial hypercholesterolemia: A systematic review and meta-analysis. J Clin Lipidol, 2019; 13: 15-30","DOI":"10.1016\/j.jacl.2018.10.012"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33) Akyol O, Yang CY, Woodside DG, Chiang HH, Chen CH, Gotto AM: Comparative analysis of atherogenic lipoproteins L5 and Lp(a) in atherosclerotic cardiovascular disease. Curr Atheroscler Rep, 2024; 26: 317-329","DOI":"10.1007\/s11883-024-01209-3"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34) Kronenberg F: Lipoprotein(a) measurement issues: are we making a mountain out of a molehill? Atherosclerosis, 2022; 349: 123-135","DOI":"10.1016\/j.atherosclerosis.2022.04.008"}],"container-title":["Journal of Atherosclerosis and Thrombosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jat\/33\/5\/33_65995\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T03:25:10Z","timestamp":1777692310000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jat\/33\/5\/33_65995\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,1]]},"references-count":34,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.5551\/jat.65995","relation":{},"ISSN":["1340-3478","1880-3873"],"issn-type":[{"value":"1340-3478","type":"print"},{"value":"1880-3873","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,1]]},"article-number":"65995"}}